<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for DRRX</title>
    <link />
    <description>Headlines for DURECT Corp</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Alkermes Changing The Standard Of Care For Schizophrenia</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1500812-alkermes-changing-the-standard-of-care-for-schizophrenia.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 13 Jun 2013 16:06:05 GMT</pubDate>
    </item>
    <item>
      <title>SmithOnStocks Opines Week Of June 2, 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1476151-smithonstocks-opines-week-of-june-2-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 03 Jun 2013 07:00:12 GMT</pubDate>
    </item>
    <item>
      <title>FDA Painkiller Abuse Concerns Creating Opportunity For Pfizer</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1446741-fda-painkiller-abuse-concerns-creating-opportunity-for-pfizer.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 09:30:40 GMT</pubDate>
    </item>
    <item>
      <title>No Relief in Sight for Pain Therapeutics Investors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/12/no-relief-in-sight-for-pain-therapeutics-investors/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 12 May 2013 15:51:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Day Update: Most Market Indices Turn Lower Again In Recent Minutes as Stock Fight to Maintain Di</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/midday-update-most-market-indices-turn-lower-again-in-recent-minutes-as-stock-fight-to-maintain-direction-cm245230.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 10 May 2013 12:23:15 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Gold Futures See Sharp Decline, Ubiquity Networks Reports Growth for Seco</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3579297/mid-morning-market-update-gold-futures-see-sharp-decline-ubiquity-networ.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 10 May 2013 10:47:14 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Gold Futures See Sharp Decline, Ubiquity Networks Reports Growth for Seco</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/midmorning-market-update-gold-futures-see-sharp-decline-ubiquity-networks-reports-growth-for-second-straight-quarter-cm245208.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 10 May 2013 10:47:14 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3579216/morning-market-losers.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 10 May 2013 10:13:47 GMT</pubDate>
    </item>
    <item>
      <title>Durect Corporation Stock Downgraded (DRRX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11915417/1/durect-corporation-stock-downgraded-drrx.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 07 May 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Durect: Pfizer Hints At Progress With Remoxy</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1398941-durect-pfizer-hints-at-progress-with-remoxy.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 10:47:54 GMT</pubDate>
    </item>
    <item>
      <title>DURECT Corporation's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1397641-durect-corporation-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 23:01:30 GMT</pubDate>
    </item>
    <item>
      <title>Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1393161-pfizer-s-efforts-boost-pain-therapeutics-and-durect-corp.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 08:05:46 GMT</pubDate>
    </item>
    <item>
      <title>DURECT Announces Submission of NDA for POSIDUR</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3499779/durect-announces-submission-of-nda-for-posidur.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 16 Apr 2013 07:29:03 GMT</pubDate>
    </item>
    <item>
      <title>3 Companies Aiming For The $1.2B Opioid Addiction Market</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1325611-3-companies-aiming-for-the-1-2b-opioid-addiction-market.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 07 Apr 2013 17:24:12 GMT</pubDate>
    </item>
    <item>
      <title>Durect Corporation And Pain Therapeutics Big Gainers For 2013?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1292301-durect-corporation-and-pain-therapeutics-big-gainers-for-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 11:30:05 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Under $5 Moving Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-under-5-moving-higher.html-2.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 19 Mar 2013 15:30:00 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1284291-acelrx-pharmaceutical-s-potential-billion-dollar-treatment-under-the-radar.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Mar 2013 08:32:00 GMT</pubDate>
    </item>
    <item>
      <title>A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282591-a-study-of-3-biotechs-a-story-of-hope-potential-and-partnerships.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Mar 2013 09:28:28 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks Ready To Rally</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1252051-3-biotech-stocks-ready-to-rally.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 13:57:05 GMT</pubDate>
    </item>
    <item>
      <title>For Durect Investors, Cash And Revenues Limit Downside</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1243891-for-durect-investors-cash-and-revenues-limit-downside.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Mar 2013 10:48:10 GMT</pubDate>
    </item>
  </channel>
</rss>
